The addition of Hospira’s IV pumps, solutions, and devices business to ICU Medical’s existing portfolio creates a leading pure-play infusion therapy company with focus and global scale
View News Article >

ICU Medical and Pfizer Inc. (NYSE: PFE) have modified the terms of the definitive agreement entered into on October 6, 2016, under which ICU Medical will acquire the Hospira Infusion Systems (HIS) business from Pfizer.
View News Article >

Agreement calls for B. Braun’s distribution of ICU Medical’s SwabCap product line to be first phase of the collaboration between the two companies to bring innovative patient safety products to the infusion therapy market worldwide
View News Article >

In commenting on the peer-reviewed study by clinicians at New York City’s Memorial Sloan Kettering Cancer Center, an editor for the New England Journal of Medicine noted that use of these devices could “markedly outweigh the added cost” in most institutions.
View News Article >

Studies showing the effectiveness of the newly launched ChemoLock system were presented yesterday at the American Society for Health-System Pharmacists Midyear meeting in Orlando, FL
View News Article >

New Version of the Microbiologically and Mechanically Closed Needlefree Automated System to Make Its European Debut at the European Association of Hospital Pharmacists (EAHP) 18th Congress in Paris March 13-15.
View News Article >

The CLC2000 has been safely used on millions of patients since 1988 and is a leading product in many markets around the world. ICU Medical intends to continue manufacturing and supporting this technology for the foreseeable future.
View News Article >

Better Business Bureau's National Advertising Division (NAD), the advertising industry’s self-regulatory forum, made the recommendations after reviewing claims made by CareFusion in Internet advertising and in promotional materials.
View News Article >